BERLIN (dpa-AFX) - Merck KGaA (MKGAY.PK), a German science and technology firm, said on Thursday that it is on track to reach its mid-term growth target of 25 billion euros in sales by 2025.
To meet the sales target, Merck said it will continue to focus on its Big 3 businesses, including Process Solutions and Life Science Services, new Healthcare products, and Semiconductor Solutions.
By 2025, Big 3 is projected to generate around 80 percent of targeted sales growth, and over 50 percent of total sales in 2025.
Until 2025, the Group expects a growth in sales organically by at least 6 percent on average per year, equating to an increase of over 1 billion euros annually.
To achieve its objectives, the company is making targeted investments worldwide to expand its regional capacities. In addition to its organic growth objectives, Merck plans further in-licensing and bolt-on acquisitions.
Copyright(c) 2022 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX